| Sep 15, 2025 |
Sep 17, 2025 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
52.5
|
-189
|
-0.35%
|
✗
|
$4.6K |
| Sep 2, 2025 |
Sep 3, 2025 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
46.3
|
-548
|
-1.01%
|
✗
|
$15.4K |
| Mar 17, 2025 |
Mar 18, 2025 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
52.5
|
-183
|
-0.38%
|
✗
|
$4.5K |
| Jan 22, 2025 |
Jan 23, 2025 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
46.3
|
-1,096
|
-2.23%
|
✗
|
$33.3K |
| Jan 17, 2025 |
Jan 21, 2025 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
91.3
|
+11,876
|
31.79%
|
✗
|
$21.4K |
| Jan 13, 2025 |
Jan 14, 2025 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
46.3
|
-783
|
-2.05%
|
✗
|
$22.5K |
| Sep 16, 2024 |
Sep 17, 2024 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
50.0
|
-192
|
-0.50%
|
✗
|
$7K |
| Sep 3, 2024 |
Sep 4, 2024 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
46.3
|
-550
|
-1.41%
|
✗
|
$21.7K |
| Mar 15, 2024 |
Mar 18, 2024 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
51.3
|
-184
|
-0.47%
|
✗
|
$10.4K |
| Jan 22, 2024 |
Jan 23, 2024 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
42.5
|
-1,061
|
-2.64%
|
✗
|
$69K |
| Jan 16, 2024 |
Jan 17, 2024 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
95.0
|
+7,448
|
22.79%
|
✗
|
$57.7K |
| Oct 23, 2023 |
Oct 24, 2023 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
52.5
|
-132
|
-0.40%
|
✗
|
$6.1K |
| Aug 31, 2023 |
Sep 1, 2023 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
46.3
|
-551
|
-1.79%
|
✗
|
$22.7K |
| Feb 21, 2023 |
Feb 22, 2023 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
91.3
|
+3,710
|
13.66%
|
✗
|
$19.5K |
| Jan 20, 2023 |
Jan 24, 2023 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
26.3
|
-919
|
-3.27%
|
✗
|
$47.8K |
| Oct 20, 2022 |
Oct 24, 2022 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
50.0
|
-130
|
-0.70%
|
✗
|
$7.5K |
| Aug 30, 2022 |
Aug 31, 2022 |
Apellis Pharmaceuticals, Inc.
|
VP/Chief Accounting Officer |
Sell |
46.3
|
-558
|
-2.92%
|
✗
|
$32.8K |